PTC Therapeutics Inc (PTCT) Insider Trading
- $31,673,582.00
- $164,427,224.94
- Aug. 5, 2025
- Stuart Walter Peltz
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Aug. 5, 2025 | CEO | 10,739 | $51.74 | Sell | $555,635.86 | |
July 15, 2025 | CFO | 2,516 | $49.46 | Sell | $124,441.36 | |
May 16, 2025 | VP | 883 | $46.02 | Sell | $40,635.66 | |
May 15, 2025 | VP | 1,929 | $46.18 | Sell | $89,081.22 | |
April 22, 2025 | CEO | 2,804 | $48.74 | Sell | $136,666.96 | |
April 2, 2025 | EVP | 897 | $46.95 | Sell | $42,114.15 | |
March 13, 2025 | Director | 5,000 | $54.00 | Sell | $270,000.00 | |
March 12, 2025 | VP | 15,521 | $53.30 | Sell | $827,269.30 | |
March 4, 2025 | Director | 1,230 | $51.52 | Sell | $63,369.60 | |
Feb. 19, 2025 | CFO | 1,168 | $50.10 | Sell | $58,516.80 | |
Feb. 19, 2025 | VP | 1,333 | $50.10 | Sell | $66,783.30 | |
Feb. 19, 2025 | EVP | 795 | $50.10 | Sell | $39,829.50 | |
Feb. 19, 2025 | Insider | 1,300 | $50.10 | Sell | $65,130.00 | |
Feb. 19, 2025 | CEO | 1,378 | $50.10 | Sell | $69,037.80 | |
Feb. 19, 2025 | CAO | 879 | $50.10 | Sell | $44,037.90 | |
Jan. 7, 2025 | VP | 1,543 | $45.34 | Sell | $69,959.62 | |
Jan. 7, 2025 | CAO | 1,291 | $45.34 | Sell | $58,533.94 | |
Jan. 7, 2025 | EVP | 810 | $45.34 | Sell | $36,725.40 | |
Jan. 7, 2025 | CEO | 1,599 | $45.34 | Sell | $72,498.66 | |
Jan. 7, 2025 | Insider | 1,265 | $45.34 | Sell | $57,355.10 | |
Dec. 31, 2024 | CEO | 8,279 | $45.16 | Sell | $373,879.64 | |
Dec. 2, 2024 | CAO | 17,800 | $51.77 | Sell | $921,506.00 | |
Dec. 2, 2024 | VP | 85,600 | $52.26 | Sell | $4,473,456.00 | |
Dec. 2, 2024 | Insider | 69,550 | $52.06 | Sell | $3,620,773.00 | |
Dec. 2, 2024 | Director | 24,000 | $51.50 | Sell | $1,236,000.00 | |
July 16, 2024 | CFO | 2,269 | $34.02 | Sell | $77,191.38 | |
May 22, 2024 | Director | 20,000 | $38.24 | Sell | $764,800.00 | |
May 7, 2024 | EVP | 175 | $32.82 | Sell | $5,743.50 | |
April 19, 2024 | CEO | 3,361 | $24.89 | Sell | $83,655.29 | |
April 17, 2024 | CEO | 787 | $25.14 | Sell | $19,785.18 | |
April 2, 2024 | EVP | 526 | $28.37 | Sell | $14,922.62 | |
Jan. 30, 2024 | Insider | 618 | $27.25 | Sell | $16,840.50 | |
Jan. 30, 2024 | VP | 794 | $27.25 | Sell | $21,636.50 | |
Jan. 30, 2024 | CAO | 318 | $27.25 | Sell | $8,665.50 | |
Jan. 22, 2024 | Director | 10,000 | $27.38 | Sell | $273,800.00 | |
Jan. 8, 2024 | CEO | 2,237 | $28.64 | Sell | $64,067.68 | |
Jan. 8, 2024 | VP | 1,457 | $28.64 | Sell | $41,728.48 | |
Jan. 8, 2024 | Insider | 1,569 | $28.64 | Sell | $44,936.16 | |
Jan. 8, 2024 | Director | 1,500 | $27.81 | Sell | $41,715.00 | |
Jan. 8, 2024 | CAO | 1,188 | $28.64 | Sell | $34,024.32 | |
Jan. 5, 2024 | CEO | 10,107 | $27.15 | Sell | $274,405.05 | |
Dec. 12, 2023 | CFO | 7,700 | $25.81 | Buy | $198,737.00 | |
Sept. 6, 2023 | Director | 11,666 | $39.86 | Sell | $465,006.76 | |
May 11, 2023 | Director | 23,000 | $55.08 | Sell | $1,266,840.00 | |
April 21, 2023 | Director | 4,328 | $55.05 | Sell | $238,256.40 | |
April 21, 2023 | CAO | 4,692 | $55.06 | Sell | $258,341.52 | |
April 18, 2023 | CEO | 1,211 | $52.04 | Sell | $63,020.44 | |
April 18, 2023 | Insider | 732 | $52.04 | Sell | $38,093.28 | |
April 17, 2023 | VP | 61,923 | $51.42 | Sell | $3,184,080.66 | |
April 17, 2023 | Director | 11,429 | $51.03 | Sell | $583,221.87 |
Insiders are both buying and selling PTC Therapeutics Inc stock.
The insider traders at PTC Therapeutics Inc are: Stuart Walter Peltz, Mark Elliott Boulding, Christine Marie Utter, Neil Gregory Almstead, Emily Luisa Hill, Eric Pauwels, Matthew B Klein, Mark Rothera, Allan Steven Jacobson, Claudia De Oliveira Ri Hirawat, Marcio Souza, David P Southwell, Lee Scott Golden, Stephanie Okey, Pierre Gravier, Dawn Svoronos, Michael Schmertzler, Shane William Charles Kovacs, Hbm Healthcare Investments (Ca, Jerome B Zeldis, Alethia Young, Adam Koppel, David Southwell, Matthew B. Klein, Michael Kranda, Michael L Kranda, Richard Aldrich, Robert J Spiegel, Robert Spiegel, and Emma Reeve
The most active insider trader at PTC Therapeutics Inc is Stuart Walter Peltz with 31 trades.
Stuart Walter Peltz has sold the most PTC Therapeutics Inc stock with a total value of $85,044,720.20.
Adam Koppel has bought the most PTC Therapeutics Inc stock with a total value of $37,500,000.00.
The most recent insider trade for PTC Therapeutics Inc was on Aug. 5, 2025.
The single biggest insider buy for PTC Therapeutics Inc was from Adam Koppel with a total value of $18,750,000.00 on June 25, 2013.
The single biggest insider sell for PTC Therapeutics Inc was from Stuart Walter Peltz with a total value of $21,253,437.00 on Dec. 7, 2020.